CHV II, L.P.

CHV II, L.P. discloses dealings in 2 companies, chiefly Phreesia, Inc. and Ocular Therapeutix, Inc. Over a trading history stretching from 30 July 2014 to 22 July 2019, the count stands at 7 filings.

In open-market terms, that means 1 purchase worth €1.5M on one side and 1 sale worth €5.4M on the other. The net balance comes to €3.9M on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. 2019 to date brings no purchases and 1 sale.

On 24 July 2019 came the latest disclosure, a transaction in Phreesia, Inc. The last insider purchase was made public on 8 August 2014, 4,476 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.